Immunology 2011 Lecture 9 Immunoglobulin Biosynthesis 3 October

Similar documents
Immunoglobulins. Harper s biochemistry Chapter 49

LECTURE: 22 IMMUNOGLOBULIN DIVERSITIES LEARNING OBJECTIVES: The student should be able to:

Basic Antibody Structure. Multiple myeloma = cancerous plasma cells Monomer = 150,000. Chapter 4. Immunoglobulin Structure and Function

Antibody Structure. Antibodies

Antibody Structure supports Function

ANTIBODIES. Agents of Immunity

1 Name. 1. (3 pts) What is apoptosis and how does it differ from necrosis? Which is more likely to trigger inflammation?

Immunoglobulins. Biological Properties

Immunoglobulins: Structure and Function

Chapter 5. Genetic Models. Organization and Expression of Immunoglobulin Genes 3. The two-gene model: Models to Explain Antibody Diversity

CHAPTER 7 CELLULAR BASIS OF ANTIBODY DIVERSITY: CLONAL SELECTION

GENETIC BASIS OF ANTIBODY STRUCTURE AND DIVERSITY. Steven J. Norris, Ph.D

Hapten - a small molecule that is antigenic but not (by itself) immunogenic.

PROF. DR. ASMAA HUSSEIN DIRECTOR OF THE MOLECULAR BIOLOGY RESEARCH UNIT

Antibody Structure and Function

Immunological Applications. Chapter 8: Background

Immunoglobulins Harry W Schroeder Jr MD PhD

Immunoglobulins have protective functions which enable the living organism to fight multiple different infections.

Chapter 2. Antibodies

1. Immunization. What is Immunization? 12/9/2016. Chapter 17: Immunization & Immune Testing. 1. Immunization 2. Diagnostic Immunology

Chapter 17: Immunization & Immune Testing. 1. Immunization 2. Diagnostic Immunology

Immunological Techniques in Research and Clinical Medicine. Philip L. Cohen, M.D. Chief of Rheumatology, LKSOM 10 March 2016

Strategies for Assessment of Immunotoxicology in Preclinical Drug Development

SPECIFICITY, DIVERSITY, AND IMMUNOGLOBULIN GENES

Serology as a Diagnostic Technique

Antibodies and Antigens in the Blood Bank 9/7/2015 NAHLA BAKHAMIS 1

Protein homology. Antigens & Antibodies I. Administrative issues:

Understanding secondary antibodies

Jaundiced Baby. Introduction to the Patient-Oriented Problem-Solving (POPS) System

Chapter 4. Antigen Recognition by B-cell and T-cell Receptors

Immunogenicity of Therapeutic Proteins. Steven J Swanson, Ph.D. Executive Director, Clinical Immunology

CHAPTER 5 COMPLEMENT

In vitro cultures of bone marrow stromal cells and progenitor B cells can accurately recapitulate the normal steps of B cell development.

B cell development The stages of B cell development

بسم هللا الرحمن الرحيم. Today we're going to talk about the generation of diversity of the receptors of the lymphocytes

IMMUNOGLOBULIN GENES UNDERGO TWO DNA REARRANGEMENTS

Immunology: Antibody Basics

Immunoglobulins. Light chain ~22-23 KDa whereas the heavy chain ~55-60 KDa

5/8/18. Function of antibodies. B-cell activation requires crosslinking of the BCR. Agenda

Assays for Immunogenicity: Are We There Yet?

Suppression of Polyclonal Immunoglobulin Production by M-proteins Shows Isotype Specificity

Atlas of Genetics and Cytogenetics in Oncology and Haematology. IMMUNOGLOBULIN GENES: CONCEPT OF DNA REARRANGEMENT * Introduction

IMMUNOCHEMICAL TECHNIQUES

chronic leukemia lymphoma myeloma differentiated 14 September 1999 Transformed Pre- Ig Surface Surface Secreted B- ALL Macroglobulinemia Myeloma

Keystone Biology Remediation B2: Genetics

Antibodies and Antigens In the blood bank

There was a reduction in number of new individuals being vaccinated / vaccine uptake was lower / higher number of babies; 1 [7]

Immunological Techniques

MEDICAL IMMUNOLOGY 544. Dr. George A. Gutman

MOLECULAR RECOGNITION

Big Idea 3C Basic Review

CHAPTER 3 ANTIBODY STRUCTURE I

Elevated Immunoglobulins and Paraproteins

Germ-line vs somatic-variation theories

Receptor Revision Diminishes the Autoreactive B Cell Response after Antigen. PNA Tet. Day 8. Day 16

Name 10 Molecular Biology of the Gene Test Date Study Guide You must know: The structure of DNA. The major steps to replication.

4 Themes in B cell development + Ig class switch and somatic mutation Tony DeFranco, 10/28/13 Checkpoints in B cell development: feedback from Ig

Bio 121 Practice Exam 3

Laboratory Procedure Handout. IMMUNOGLOBULIN M IgM

Molecular Genetics Quiz #1 SBI4U K T/I A C TOTAL

Immunotherapy in myeloma

FELLOWSHIP PROGRAM IN CLINICAL IMMUNOLOGY

A Level. A Level Biology. DNA Technology Questions. AQA, OCR, Edexcel. Name: Total Marks: Page 1

Unit 6: DNA and Protein Synthesis Guided Notes

Biomarkers, Early Prediction of Vaccine Efficacy and Safety

Chapter 3 The Immune System

Diagnostic Microbiology

Platelet Refractoriness: The Basics. Martin H. Bluth, MD, PhD

Antigen-Antibody Interaction

Serum heavy-light chain analysis (Hevylite): clinical applications for multiple myeloma

Lecture 25 (11/15/17)

Chapter 9. First symmetry

7.06 Cell Biology QUIZ #3

Human Rheumatoid Factor IgM ELISA Kit

T and B cell gene rearrangement October 17, Ram Savan

Assays and Strategies for Immunogenicity Assessment. Steven J Swanson, Ph.D. Executive Director, Medical Sciences Clinical Immunology, Amgen

Introducing new DNA into the genome requires cloning the donor sequence, delivery of the cloned DNA into the cell, and integration into the genome.

Implementation of the Next Generation Effector Function Assays for Comparability Assessments

Western-GUARANTEED Antibody Service FAQ

Chapter 11. How Genes Are Controlled. Lectures by Edward J. Zalisko

Antigen-antibody reactions with labeled reagents

HOST DEFENSE SMALL GROUP PROBLEM SOLVING SESSION CLINICAL IMMUNOLOGIC ASSAYS-II

A guide to selecting control, diluent and blocking reagents

Mechanisms of extravascular destruction of red cells coated with IgG1 or IgG3 (± C3b).

COMMITTEE FOR PROPRIETARY MEDICINAL PRODUCTS (CPMP)

Primer on Genome Biology Part I: Fundamentals

Multiple myeloma (MM) & related disorders

FORENSIC SEROLOGY. Chapter PRENTICE HALL 2008 Pearson Education, Inc. Upper Saddle River, NJ 07458

Cytomics in Action: Cytokine Network Cytometry

See more signal with less noise

Step-by-Step Description of ELISA

Immunogenicity of biotherapeutics; an introduction

Higher National Unit specification General information Unit title: Unit code: Superclass: Publication date: Source: Version: Unit purpose Outcomes

DTT Treated Reagent Red Cells for use in Resolving DARA Interference. More Than Just Kell?? Marilyn Stewart MT(ASCP)SBB

Immunology- Mic : First observed by Gruber and Durham when serum antibody was found to react with bacterial cells.

Immunophenotyping of Peripheral Blood and Bone Marrow Cells by Flow Cytometry *Akanni EO and # Palini A.

Strategies to Improve Drug Tolerance in Nab Assays

OmniAb. Naturally optimized human antibodies

Transcription:

Immunology 2011 Lecture 9 Immunoglobulin Biosynthesis 3 October

APC Antigen processing (dendritic cells, MΦ et al.) Antigen "presentation" Ag/Ab complexes Antigenspecific triggering B T ANTIGEN Proliferation Differentiation T H2 T H1 T-cell "help" Complement AFC ANTIBODY T-CELL FUNCTIONS TC Killing of bacteria Inflammation Inactivation of viruses Allergy T-cell killing: virus-infected cells, transplants Mixed Lymphocyte Reaction (MLR) Delayed type hypersensitivity, (DTH); e.g. tuberculin reaction AUTOIMMUNITY T reg Tolerance, suppression AFFERENT CENTRAL EFFERENT THREE "LIMBS" OF THE IMMUNE RESPONSE

OUTLINE: Ig BIOSYNTHESIS Synthesis/Assembly Secretion (x2) Memory Key Features 1 cell - 1 Ab Allelic Exclusion Isotype Switching Membrane vs. secreted Ig Problem Set #2 Answer Key on web site

Stem cell µ Pre-B cell (H-chain only, cytoplasm) Immunoglobulin Expression IgM IgD B-cells (IgM & IgD, membrane) Markers Gene rearrangements Membrane molecules in the B-cell Lineage IgM Plasma cell (secreted IgM)

Components of Immunoglobulin Light Chains Heavy Chains CHO (only on CH) J-Chain (IgM, [IgA]2,3) Secretory Piece (siga)

IMMUNOGLOBULIN BIOSYNTHESIS mrna conventional mrna L V C AAAAA RER translation Peptides L translocation/cleavage NUCLEUS pre-mrna V C V C H CYTOPLASM continuous addition of CHO CHO H-H H-H-L L-H-H-L GOLGI H-L spontaneous assembly of H & L-chains Assembly transport to Golgi, PG vesicles secreted IgG Post-Golgi vesicles release from cell (plasma cell) Secretion secreted IgM IgM (or IgA) +J-Chain) addition of J-chain Membrane IgG (or IgMS) membranebound Ig (B-cell)

Carbohydrate on Immunoglobulins Oligosaccharides on Ig are heterogeneous and vary over time. Percent of G0 forms (no galactoses) correlates with disease progression in RA; exposed NAcGlu reacts with MBLectin. Terminal sialic acids decrease affinity of IgG for some Fc receptors; induce expression of an inhibitory FcR on MΦ responsible for protective (anti-inflammatory) effects of IVIg?? See commentary by Burton & Dwek, Science 313:627, 2006

Components of Immunoglobulin Light Chains Heavy Chains CHO (only on CH) J-Chain (IgM, [IgA]n) Secretory Piece (siga)

Secretory IgA LUMEN (IgA)2 S S f (IgA)2 S p (IgA)2 (IgA)2 (IgA)2 EXTRACELLULAR SPACE TRANSPORT OF EXOCRINE IgA Selective transport of polymeric IgA (participation of J-chain) Addition of S-piece to secreted molecule

Key Features of Immunoglobulin Biosynthesis 1) An AFC produces only one kind of Ab only one heavy chain isotype only one light chain isotype only one kind of VH and one VL The two halves of IgG are identical Stretching the rules Virgin B-cell may produce both IgM & IgD B-cells bearing mig will shift to secreting Ig, transiently expressing both (likewise for cells during the process of isotype switching).

If an AFC were to produce two different L- chains Two different antigen-binding sites: V L 1 + V H = S1 V L 2 + V H = S2 Three different IgG molecules, 50% asymmetric: S1 S1 S2 S1 S2 S2 For 2V L + 2V H - even more combinations

Key Features of Immunoglobulin Biosynthesis 2) Allelic exclusion for H-chains & L-chains Only one of two chromosomes is expressed (although both may be rearranged). Ensures symmetry of Ig - 2 identical combining sites Single-cell level only; overall expression is co-dominant 3) Heavy chain class switching Change CH only, retain VH & entire L-Chain Unidirectional Functional diversity; cheaper molecules (compared with IgM) 4) Secreted vs. membrane Ig Alternate RNA splicing selects anchoring exon All Ig isotypes Membrane receptor = Ab which will be secreted

Allelic exclusion is critically important for antibodies...but it is not unique to Ig. Monoallelic expression once thought to be rare may represent ~5% of all genes in human somatic cells. Gimelbrant et al., Science 318:1136, 2007

B-cell Triggering: Proliferation and Differentiation IgD IgM B V B V = "virgin" B-cell primary response AFC = antibody-forming cell B M = "memory" B-cell = differentiation = with class switching and somatic mutation IgG IgG = with somatic mutation AFC AFC AFC AFC B M B M secondary response Secreted Ab (IgM) IgG IgG IgG IgE AFC AFC AFC AFC AFC AFC B M B M B M B M Figure 9-3 Secreted Ab (IgG) IMMUNOGLOBULIN EXPRESSION BY B-CELLS AND THEIR PROGENY

Antibody responses, B-cells and T-cells, are polyclonal. Tumors (myelomas, lymphomas, leukemias) are monoclonal Implications of Tumor Monoclonality 1) Can distinguish between different forms of lymphoproliferative disease (e.g. stain for κ vs. λ, or use Southern blots to analyze gene rearrangements). Treatment & prognoses are different for monoclonal vs. polyclonal gammopathies. 2) Anti-idiotype therapy may be possible for some B-cell and T- cell tumors, since they are monoclonal (but there are practical limitations).

TUESDAY ABO & Rh Blood Groups, Chapter 10 THURSDAY Inbreeding, Appendix 10 MHC & Transplantation, Chapter 11

Problem Set 2: Complement fixation assay Lysis with Lysis with Test added no added Sample Dilution antibody antibody -------------------------------------------- #1 1:100 - + 1:200 - + 1:400 - + 1:800 + + <-- Endpoint is at 1:400 #2 1:100 - + 1:200 + + 1:400 + + 1:800 + + #3 1:100 - - 1:200 - - 1:400 + + 1:800 + + <-- Endpoint is at 1:100 (amount of viral antigen is about four times less than in sample #1) This serum sample is "anti-complementary ; Complement is consumed even without the addition of specific Ab. One can only conclude that the true endpoint must be less than 1:400 (but could be zero!).

Problem Set 2: One Shot Serum Sickness "biological clearance" "immune clearance" AMOUNT immune complexes free Ab 1 2 3 wks Primary 1 2 3 wks o 2, no remaining Ab 1 2 3 wks o 2, remaining Ab

Gm Genetics Problems All heavy chain loci are closely linked (we ignore the possibility of crossing-over) All allelic forms are known, assumption of homyzygosity is good.

Gm Genetics Problem 3. Fred and Wilma Flintstone and their daughter Pebbles have been typed for allotypes of IgG1 and IgG3 with the following results: Fred: G1m (1+); G3m (5+ 11+) Wilma: G1m (1+ 2+); G3m (6+ 7+) Pebbles: G1m (1+2+); G3m (6+11+) Which of the following would be the LEAST likely phenotype for their second child? A. G1m (1+); G3m (7+11+) B. G1m (1+ 2+); G3m (5+ 6+) C. G1m (1+ 2+); G3m (6+ 11+) D. G1m (1+ 2+); G3m (7+ 11+) E. G1m (1+); G3m (5+ 7+)

Fred Wilma 1 5 1 6X 7 1 11 2 7X 6? G1m G3m G1m G3m Pebbles 1 X 6 11 2 11 X 6 G1m G3m? Four possible phenotypes: G1m(1+);G3m(5+7+) G1m(1+2+);G3m(5+6+) G1m(1+);G3m(7+11+) G1m(1+2+);G3m(6+11+) Very unlikely: G1m (1+ 2+); G3m (7+ 11+)

Gm Genetics Problem 3. Fred and Wilma Flintstone and their daughter Pebbles have been typed for allotypes of IgG1 and IgG3 with the following results: Fred: G1m (1+); G3m (5+ 11+) Wilma: G1m (1+ 2+); G3m (6+ 7+) Pebbles: G1m (1+2+); G3m (6+11+) Which of the following would be the LEAST likely phenotype for their second child? A. G1m (1+); G3m (7+11+) B. G1m (1+ 2+); G3m (5+ 6+) C. G1m (1+ 2+); G3m (6+ 11+) D. G1m (1+ 2+); G3m (7+ 11+) E. G1m (1+); G3m (5+ 7+)